Viewing Study NCT00022633

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2025-12-27 @ 11:14 PM
Study NCT ID: NCT00022633
Status: TERMINATED
Last Update Posted: 2016-08-11
First Post: 2001-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
Sponsor: SWOG Cancer Research Network
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
None Transitional Cell Cancer of the Renal Pelvis and Ureter View
None Urethral Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent bladder cancer View
None stage IV bladder cancer View
None transitional cell carcinoma of the bladder View
None squamous cell carcinoma of the bladder View
None adenocarcinoma of the bladder View
None recurrent urethral cancer View
None anterior urethral cancer View
None posterior urethral cancer View
None urethral cancer associated with invasive bladder cancer View
None metastatic transitional cell cancer of the renal pelvis and ureter View
None regional transitional cell cancer of the renal pelvis and ureter View
None recurrent transitional cell cancer of the renal pelvis and ureter View